Answers are grounded in this paper and cite their sources.
This is a report on the current new markers in the serum for prostate cancer diagnosis and follow-up, which were discussed at this International Union Against Cancer (UICC) Tumor Biology Committee Program Meeting held in Whistler, British Columbia, Canada, on July 17–18, 1999.
No takes yet. Share an insight, caveat, or question.
Partin et al. (2000) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: